Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Visteon (VC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Visteon (VC) over the last 17 years, with Q3 2025 value amounting to $762.0 million.

  • Visteon's Cash & Equivalents rose 3854.55% to $762.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $762.0 million, marking a year-over-year increase of 3854.55%. This contributed to the annual value of $623.0 million for FY2024, which is 2097.09% up from last year.
  • Per Visteon's latest filing, its Cash & Equivalents stood at $762.0 million for Q3 2025, which was up 3854.55% from $668.0 million recorded in Q2 2025.
  • Over the past 5 years, Visteon's Cash & Equivalents peaked at $762.0 million during Q3 2025, and registered a low of $322.0 million during Q2 2022.
  • In the last 5 years, Visteon's Cash & Equivalents had a median value of $484.0 million in 2023 and averaged $505.5 million.
  • As far as peak fluctuations go, Visteon's Cash & Equivalents plummeted by 4136.25% in 2021, and later surged by 4130.43% in 2023.
  • Visteon's Cash & Equivalents (Quarter) stood at $452.0 million in 2021, then rose by 15.04% to $520.0 million in 2022, then dropped by 0.96% to $515.0 million in 2023, then grew by 20.97% to $623.0 million in 2024, then grew by 22.31% to $762.0 million in 2025.
  • Its Cash & Equivalents was $762.0 million in Q3 2025, compared to $668.0 million in Q2 2025 and $655.0 million in Q1 2025.